Nitromint (Glyceryl Trinitrate Solution)

Glyceryl trinitrate donates nitric oxide, which activates the enzyme guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, causing relaxation of veins and arteries, lowering cardiac preload and afterload, and thereby decreasing myocardial oxygen consumption.

The exact dose of Nitromint is determined by the prescribing clinician based on the patient’s condition and response. Typical sublingual dosing may start with a low milligram amount, but the prescriber sets the precise regimen.

Safety data for glyceryl trinitrate during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Nitromint, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitromint belongs to the organic nitrate class, offering rapid relief of chest pain, whereas beta‑blockers and calcium‑channel blockers provide longer‑term control of heart rate and vascular tone. Nitrates act directly on vascular smooth muscle, while other classes modulate cardiac output or calcium influx.

Nitromint should be stored at ambient temperature, below 25 °C, in its original container. Keep the solution away from moisture, direct sunlight and heat sources. Do not freeze or expose the bottle to extreme temperature fluctuations.

Place the prescribed number of drops under the tongue and allow it to dissolve completely without swallowing. The patient should remain seated or lying down for a few minutes to avoid dizziness. Do not eat, drink, or smoke until the medication has taken effect.

Serious risks include severe hypotension, reflex tachycardia, methemoglobinemia, and rare allergic reactions such as anaphylaxis. Patients should be instructed to seek immediate medical attention if they experience fainting, rapid heartbeat, bluish skin discoloration, or signs of a severe allergic response.

Nitromint is contraindicated in patients with known hypersensitivity to glyceryl trinitrate or other nitrates, those with severe hypotension, and individuals who have taken phosphodiesterase‑5 inhibitors within the previous 24‑48 hours. Caution is also advised for patients with certain cardiac conditions, such as hypertrophic cardiomyopathy.